secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2024-03-27T23:59:59+00:00
Accession:  0001798749-24-000018
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate Therapeutics furnishes corporate presentation; no material news disclosed
--------------------------------------------------------------------------------

- Filed under Item 7.01 as Regulation FD disclosure; presentation used for investor meetings starting March 27, 2024.
- Presentation focuses on pipeline for pulmonary arterial hypertension; no new clinical or financial data provided.
- No specific numbers, milestones, or guidance changes were included in the exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000018/0001798749-24-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000018/tmb-20240327x8k.htm
  HTML page:      https://secwatch.observer/filing/0001798749-24-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer